Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

ASTRA ZENECA PHARMACEUTICALS LP;GLOBAL INTELLECTUAL PROPERTY

WILMINGTON, DE US

1. 20110046191 COMBINATION OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2-ADRENOCEPTOR AGONIST 02-24-2011
2. 20110039858 Novel Compounds - at least one compound of general formula I STR00001 wherein R 02-17-2011
3. 20110028489 Pyrimidine Derivatives and Their Use for Treating Bone-Related Disorders 02-03-2011
4. 20110021540 Bis-(Sulfonylamino) Derivatives in Therapy 066 01-27-2011
5. 20100331341 2-CARBOXAMIDE-7-PIPERAZINYL-BENZOFURAN DERIVATIVES 774 12-30-2010
6. 20100331321 Bis-(Sulfonylamino) derivatives for use in therapy 12-30-2010
7. 20100330179 Method for Treating a Patient at Risk for Developing an NSAID-associated Ulcer 12-30-2010
8. 20100324072 PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS BACE INHIBITORS 12-23-2010
9. 20100324044 METABOTROPIC GLUTAMATE RECEPTOR ISOXAZOLE LIGANDS AND THEIR USE AS POTENTIATORS 12-23-2010
10. 20100317674 Metabotropic Glutamate-Receptor-Potentiating Isoindolones 12-16-2010
11. 20100317662 Metabotropic Glutamate Receptor Isoxazole Ligands and Their Use as Potentiators - 286 12-16-2010
12. 20100305140 BENZIMIDAZOLE DERIVATIVES WHICH ARE TO BE USED AS ANTAGONIST FOR THE CB1-RECEPTOR 12-02-2010
13. 20100298340 Thiazol-Guanidine Derivatives Useful As A (Beta)-Related Pathologies 11-25-2010
14. 20100292279 Bis-(Sulfonylamino) Derivatives in Therapy 11-18-2010
15. 20100292210 Novel Compounds for A-Beta-Related Pathologies 11-18-2010
16. 20100286392 PROCESS FOR THE MANUFACTURING OF THE COMPOUND 2-HYDROXY-3-[5-(MORPHOLIN-4-YLMETHYL)PYRIDIN-2-YL]1H-INDOLE-5-CARBONITRIL- E 701 11-11-2010
17. 20100286202 New Compounds - STR00001 or salts solvates or solvated salts thereof 11-11-2010
18. 20100280082 Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as Potentiators 11-04-2010
19. 20100267740 Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators - 842 10-21-2010
20. 20100267723 Imidazole Substituted Pyrimidines - compound of formula STR00001 wherein R 10-21-2010
21. 20100267720 Crystalline Forms of 2-Hydroxy-3- [5- (Morpholin- 4- Ylmethyl) Pyridin-2-YL] IH- Indole- 5 -Carbonitrile Citrate 10-21-2010
22. 20100234593 Imidazo[4,5-B]Pyridine-7-Carboxamides 704 09-16-2010
23. 20100216812 Cyclopropyl Amide Derivatives - Disclosed herein is at least one cyclopropyl amide derivative at least one pharmaceutical composition comprising at 08-26-2010
24. 20100184738 Uses of cinnoline compounds to treat schizophrenia 07-22-2010
25. 20100179199 Ethanamine Compounds and Methods of Using the Same 545 07-15-2010
26. 20100173941 Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer's Disease and Schizophrenia 07-08-2010
27. 20100173935 Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer's Disease and Schizophrenia 07-08-2010
28. 20100173890 Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease 07-08-2010
29. 20100168146 Composition Comprising (R)-Spiro[L-Azabicyclo[2.2.2]Octane-3,2'(3'H)-Furo[2,3-B]Pyridine (AZD0328) and its Use in the Treatment of Alzheimer's Disease, ADHD or Cognitive Dysfunction 07-01-2010
30. 20100168130 Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof 07-01-2010
31. 20100168105 Spirocyclopropyl Piperidine Derivatives - Disclosed herein is at least one piperidine derivative at least one pharmaceutical composition comprising at 07-01-2010
32. 20100160374 N-(2-Hydroxyethyl)-N-Methyl-4-(Quinolin-8-yl(1-(Thiazol-4-ylmethyl)Piperid- in-4-ylidene)Methyl)Benzamide 06-24-2010
33. 20100152197 (4-TERT-BUTYLPIPERAZIN-2-YL)(PIPERAZIN-1-YL)METHANONE-N-CARBOXAMIDE DERIVATIVES 06-17-2010
34. 20100144852 Bicyclo[2.2.1]hept-7-ylamine Derivatives and Their Uses 06-10-2010
35. 20100144710 Piperazine and Piperidine MGLUR5 Potentiators 06-10-2010
36. 20100144606 COMBINATION 408 - pharmaceutical product, kit or composition comprising a first active ingredient which is N-Cyclohexyl-N 06-10-2010
37. 20100137330 Use - new use of a compound of the formula STR00001 wherein R 06-03-2010
38. 20100137322 NOVEL N-(8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N-(5-HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN 06-03-2010
39. 20100130495 COMPOUNDS 563 - novel compounds of formula I and therapeutically acceptable salts thereof 05-27-2010
40. 20100130477 Spirocyclobutyl Piperidine Derivatives - Disclosed herein is at least one spirocyclobutyl piperidine derivative at least one pharmaceutical composition 05-27-2010
41. 20100125087 NEW COMPOUNDS 575 - novel compounds of formula and their pharmaceutical compositions 05-20-2010
42. 20100125082 NEW COMPOUNDS 578 - novel compounds of formula and their pharmaceutical compositions 05-20-2010
43. 20100125081 NEW COMPOUNDS 574 - novel compounds of formula and their pharmaceutical compositions 05-20-2010
44. 20100120850 Quinoline Derivatives, Pharmaceutical Compositions Comprising Them, and Their Use in Treating Central Nervous System and Peripheral Diseases 05-13-2010
45. 20100113540 Azole and Thiazole Derivatives and Their Use 05-06-2010
46. 20100113510 QUINUCLIDINOL DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS 05-06-2010
47. 20100113502 Novel Tetrahydro-1H-Pyrido[4,3-b] Indole Derivatives as CB1 Receptor Ligands 05-06-2010
48. 20100105657 Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease 04-29-2010
49. 20100105642 NOVEL COMPOUNDS 409 - compound of formula STR00001 wherein W, R 04-29-2010
50. 20100098631 Novel-2-Heteroaryl Substituted Indoles 695 04-22-2010
51. 20100093816 SALT - The invention provides [2--ethyl]-[2--cyclohexyl-hydroxy-phenyl-methyl)-- oxazol-5-yl-methyl]-dimethyl-ammonium napadisylate 04-15-2010
52. 20100093813 Salts 668 - pharmaceutically acceptable salt of N-[2-ethyl]-N 04-15-2010
53. 20100093700 Methods of Treating Mood Disorders - method of treating at least one symptom or condition associated with but not limited to: Mood Disorders including 04-15-2010
54. 20100093699 COMPOUNDS AND USES THEREOF - 177 - This invention relates to novel compounds having the structural Formula below: and their pharmaceutically acceptable 04-15-2010
55. 20100092385 Novel Heteroaryl Substituted Imidazo [1,2-A] Pyridine Derivatives 04-15-2010
56. 20100087396 Novel Compounds Having Selective Inhibiting Effect at GSK3 04-08-2010
57. 20100081660 Novel Compounds Having Selective Inhibiting Effect at GSK3 04-01-2010
58. 20100075989 Novel Compounds Having Selective Inhibiting Effect at GSK3 03-25-2010
59. 20100062064 Method for Delivering A Pharmaceutical Composition to Patient in Need Thereof 03-11-2010
60. 20100056796 Compounds Suitable As Precursors to Compounds that are Useful for Imaging Amyloid Deposits 03-04-2010
61. 20100056565 Heterocyclic Derivatives as M3 Muscarinic Receptors 03-04-2010
62. 20100056508 AMINE DERIVATIVES AND THEIR USE IN BETA-2-ADRENORECEPTOR MEDIATED DISEASES 03-04-2010
63. 20100056492 COMPOUNDS AND USES THEREOF - 152 - This invention relates to novel compounds having the structural Formula below: and their pharmaceutically acceptable 03-04-2010
64. 20100041706 Compounds 501 - novel crystalline form of 4--1-[5-isoxazol-3-yl]ethoxy}-4-methyl-4H-1,2,4-t- riazol-3-yl)pyridine 02-18-2010
65. 20100035899 5,7-DISUBSTITUTED[1.3]THIAZOLO[4,5-d]PYRIMIDIN-2(3H)-AMINE DERIVATIVES AND THEIR USE IN THERAPY 02-11-2010
66. 20100029732 Combinations of Beta-2-Adrenoceptor Agonistic Benzothiazolone 02-04-2010
67. 20100029717 Alkylsulphonamide Quinolines - Compounds of Formula I STR00001 wherein R 02-04-2010
68. 20100029713 QUINICLIDINE DERIVATIVES OF (HETERO) ARYLCYCLOHEPTANECARBOXYLIC ACID AS MUSCARINIC RECEPTOR ANTAGONISTS 02-04-2010
69. 20100022610 New Crystalline Forms - salt of the compound N-{2-tert-butyl-1-[methyl]-1H-benzimidazol-5-yl}e- thanesulfonamide which is an ethanesulphonic acid salt 01-28-2010
70. 20100022545 Metabotropic Glutamate Receptor Isoxazole Ligands and Their Use as Potentiators - 286 01-28-2010
71. 20100022491 4-HYDROXY-2-OXO-2,3-DIHYDRO-1,3-BENZOTHIAZOL-7YL COMPOUNDS FOR MODULATION OF B2-ADRENORECEPTOR ACTIVITY 01-28-2010
72. 20100016284 COMPOUNDS AND USES THEREOF - 151 - This invention relates to novel compounds having the structural Formula I below: and their pharmaceutically 01-21-2010
73. 20100016283 COMPOUNDS AND USES THEREOF - 150 - Formula below: and their pharmaceutically acceptable salts or tautomers, compositions and methods of use thereof 01-21-2010
74. 20090318415 DIBENZOTHIAZEPINE DERIVATIVES AND USES THEREOF - 424 12-24-2009
75. 20090312322 Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3 12-17-2009
76. 20090306158 Metabotropic Glutamate Receptor Isoxazole Ligands and Their Use as Potentiators 286 12-10-2009
77. 20090291983 3-Oxoisoindoline-1-Carboxamide Derivatives as Analgesic Agents 11-26-2009
78. 20090291982 New Substituted Oxindole Derivative 352 - new compound of formula STR00001 6-pyridine-3-carboxylic acid or a pharmaceutically acceptable salt thereof 11-26-2009
79. 20090291966 Method Of Treating Anxious Major Depressive Disorder 11-26-2009
80. 20090286813 Thioxanthine Derivatives and Their Use as Inhibitors of MPO 11-19-2009
81. 20090281138 Bis-(Sulfonylamino) Derivatives in Therapy 066 11-12-2009
82. 20090275574 NOVEL COMPOUNDS-300 - Compounds of Formula I, or pharmaceutically acceptable salts thereof: STR00001 wherein R 11-05-2009
83. 20090270470 Compounds I - Compounds of formula I STR00001 wherein R1 Z 10-29-2009
84. 20090253126 Biomarker Detection Assays - method for identifying compounds capable of modulating the Notch pathway 10-08-2009
85. 20090221657 Compounds, Compositions Containing Them, Preparation Thereof and Uses Thereof I 09-03-2009
86. 20090221642 MUSCARINIC RECEPTOR AGONISTS, COMPOSITIONS, METHODS OF TREATMENT THEREOF, AND PROCESSES FOR PREPARATION THEREOF-176 09-03-2009
87. 20090221576 Pharmaceutical Use of 2-Hydroxy-3-[5-(Morpholin-4-Ylmethyl) Pyridin-2-YL]-1H-IN-Dole-5-Carbonitrile as a Free Base or Salts 09-03-2009
88. 20090221567 MUSCARINIC RECEPTOR AGONISTS, COMPOSITIONS, METHODS OF TREATMENT THEREOF, AND PROCESSES FOR PREPARATION THEREOF 177 09-03-2009
89. 20090215841 D2 Receptor Ligand-078 - This invention relates to the compound of Formula I and pharmaceutically acceptable salts thereof: STR00001 -N*6*-ethyl-6 08-27-2009
90. 20090192190 Benzoic Acid Derivatives that are Modulators or Agonists of GlyR 07-30-2009
91. 20090192180 Alpha-7 Nicotinic Receptor Agonists and Statins In Combination 07-30-2009
92. 20090181968 Novel 3-Bicyclocarbonylaminopyridine-2-Carboxamides or 3-Bicyclocarbonylaminopyrazine-2-Carboxamides 07-16-2009
93. 20090176851 Use of Spiro [Imidazolidine-4, 3' -Indole] 2, 2', 5' (1H) Triones for Treatment of Conditions Associated with Vanilloid Receptor 1 07-09-2009
94. 20090170851 Chroman Compounds - Compounds according to Formula : STR00001 wherein R 07-02-2009
95. 20090163586 Bis-(Sulfonylamino) Derivatives in Therapy 205 06-25-2009
96. 20090156625 Novel Use of a Nicotinic Receptor Agonist 156 06-18-2009
97. 20090149505 Metabotropic Glutamate Receptor-Potentiating Isoindolones 06-11-2009
98. 20090149475 Thioxanthine Derivatives and Their Use as Inhibitors of MPO 06-11-2009
99. 20090149460 New Compounds - of formula Ia and Ib: STR00001 as well as a process for their preparation and new intermediates used therein 06-11-2009
100. 20090137650 New Compounds - of formula I, STR00001 where R 05-28-2009
101. 20090131468 Bis-(Sulfonylamino) Derivatives in Therapy 065 05-21-2009
102. 20090131459 2-Thioxanthine Derivatives Acting as MPO-Inhibitors 05-21-2009
103. 20090124640 Pyrrolo[3,2-D]Pyrimidin-4-One Derivative as Myeloperoxidase Inhibitor 05-14-2009
104. 20090124637 Novel 5,7-Disubstituted [1,3]Thiazolo[4,5-D]Pyrimidin-2(3H)-One Derivatives 794 05-14-2009
105. 20090111865 Benzimidazole Derivatives, Compositions Containing Them, Preparation Thereof and Uses Thereof 04-30-2009
106. 20090105252 Pyrimidine Derivatives and Their Use in Therapy as well as the Use of Pyrimidine Derivatives in the Manufacture of a Medicament for Prevention and/or Treatment of Alzheimer's Disease 04-23-2009
107. 20090099195 Therapeutic Compounds 570 - Compounds of formula I or pharmaceutically acceptable salts thereof: STR00001 wherein R 04-16-2009
108. 20090099187 Novel 8-Sulfonyl-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5HT6 Receptor 04-16-2009
109. 20090076078 New compounds 966 - Compounds of Formula I, or pharmaceutically acceptable salts thereof: STR00001 wherein R 03-19-2009
110. 20090076064 Compounds - Disclosed are compounds of Formula wherein G, R 03-19-2009
111. 20090076049 Novel Spiro [Imidazolidine-4, 3' -Indole] 2, 2', 5' (1H) Triones for Treatment of Conditions Associated with Vanilloid Receptor 1 03-19-2009
112. 20090076020 Cyclopropyl Amide Derivatives 978 - Disclosed herein is at least one cyclopropyl amide derivative at least one pharmaceutical composition comprising at 03-19-2009
113. 20090062282 Substituted Amino-Pyrimidones and Uses Thereof 03-05-2009
114. 20090062251 Novel Compounds 002 - Compounds of Formulae I, or pharmaceutically acceptable salts thereof: STR00001 wherein R 03-05-2009
115. 20090054468 New Use 938 - the use of MPO inhibitors for the treatment of multiple system atrophy 02-26-2009
116. 20090054453 Novel Tetralins as 5-HT6 Modulators - new compounds of formula I, or salts, solvates or solvated salts thereof, wherein Q, R 02-26-2009
117. 20090054445 Amide Substituted Quinolines - Compounds of Formula I STR00001 wherein R 02-26-2009
118. 20090053176 New Combination 937 - The present invention related to a combination of a compound which is a MPO inhibitor or a pharmaceutically acceptable salt 02-26-2009
119. 20090036454 Compounds and Uses Thereof - This invention relates to novel compounds having the structural formula I below: STR00001 and their pharmaceutically 02-05-2009
120. 20090030038 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor 01-29-2009
121. 20090030033 Novel Compounds 894 01-29-2009
122. 20090028787 Novel Heteroaryl Substituted Benzothiazoles 01-29-2009
123. 20090023732 Citrate Salt of an Indole Derivative and its Pharmaceutical Use 01-22-2009
124. 20090023728 1,2,3,4-Tetrahydroisoquinoline Derivatives, Preparations Thereof and Uses Thereof 01-22-2009
125. 20090023711 Piperazines and Piperidines as Mglur5 Potentiators 01-22-2009
126. 20090018130 Derivatives of 5-Aryl-1H-Pyrrolo [2, 3B] Pyridine-3-Carboxamide or 5-Aryl-1H-Pyrrolo [2, 3B] Pyridine-3-Carboxylic Acid 01-15-2009
127. 20090018112 Compounds and Uses Thereof - This invention relates to novel compounds having the structural formula I below: STR00001 and their pharmaceutically 01-15-2009
128. 20090012127 Thiophene-2-Carboxamide Derivatives as Alpha 7 Nicotinic Receptor Modulators 01-08-2009
129. 20090004106 Radioligands for the 5 -Ht1b Receptor - novel radioligands for the 5-HT 01-01-2009
130. 20080318981 Novel Compounds 480 - There are disclosed novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2-one derivatives of formula wherein R 12-25-2008
131. 20080318943 Compounds and Uses Thereof - 848 - This invention relates to novel compounds having the structural formula I below: and their pharmaceutically 12-25-2008
132. 20080318925 Compounds and Uses Thereof - 849 - This invention relates to the use of compounds having the structural formula I below: and their pharmaceutically 12-25-2008
133. 20080312311 Crystalline forms of 3-(2R-tetrahydrofuryl-methyl)-2-thioxanthine 12-18-2008
134. 20080306110 Alkylnitrile Quinolines as Nk-3 Receptor Ligands 12-11-2008
135. 20080306107 Compounds - new compounds of formula wherein R 12-11-2008
136. 20080306088 Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as Potentiators 841 12-11-2008
137. 20080306087 Therapeutic Agents - compounds of formula and processes for preparing such compounds their use in the treatment of obesity 12-11-2008
138. 20080306077 Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators 842 12-11-2008
139. 20080293765 Alkylsulphonamide Quinolines - Compounds of Formula I wherein R 11-27-2008
140. 20080293748 Thioxanthine Derivatives as Myeloperoxidase Inhibitors 11-27-2008
141. 20080287492 Alkylpyridyl Quinolines as Nk3 Receptor Modulators 11-20-2008
142. 20080287418 Extended Release Compositions and Methods for Their Manufacture 11-20-2008
143. 20080287399 Substituted Aminopyridines and Uses Thereof 11-20-2008
144. 20080280949 Oxopyridyl Quinoline Amides as Nk3 Receptor Modulators 11-13-2008
145. 20080275041 3-Heterocyclyl-Indole Derivatives as Inhibitors of Glycogen Synthase Kinase-3 (Gsk-3) 11-06-2008
146. 20080274096 Fusion Proteins Having a Modulated Half-Life in Plasma 11-06-2008
147. 20080269275 Novel Mchr1 Antagonists and Their Use for the Treatment of Mchr1 Mediated Conditions and Disorders 10-30-2008
148. 20080262038 Diarylmethylidene Piperidine Derivatives, Preparations Thereof and Uses Thereof 10-23-2008
149. 20080255106 Novel 2-Phenyl-Imidazo[4,5-B]Pyridine Derivatives as Inhibitors of Glycogen Synthase Kinase for the Treatment of Dementia and Neurodegenerative Disorders 10-16-2008
150. 20080255085 Novel Imidazo [4,5-b] Pyridine Derivatives as Inhibitors of Glycogen Synthase Kinase 3 for Use in the Treatment of Dementia and Neurodegenerative Disorders 10-16-2008
151. 20080242688 Method 741 - Methods of treatment and pharmaceutical compositions for providing improved cognition in subjects suffering from schizophrenia 10-02-2008
152. 20080242590 New Method 706 - fusion proteins and their use in enzymatic treatment of Alzheimer's disease patients 10-02-2008
153. 20080234274 Novel Compounds - compounds and compositions for treating diseases associated with cysteine protease activity 09-25-2008
154. 20080234269 N-Oxo-Heterocycle and N-Oxo-Alkyl Quinoline-4-Carboxamides as Nk-3 Receptor Ligands 09-25-2008
155. 20080221188 New Benzimidazole Derivatives - Provided herein are compounds in accord with Formula I: that are useful in the treatment of pain 09-11-2008
156. 20080221178 Benzimidazole Derivatives,Compositions Containing Them, Preparation Thereof and Uses Thereof 09-11-2008
157. 20080221149 Novel 2-Heteroaryl Substituted Benzothiophenes and Benzofuranes 709 09-11-2008
158. 20080221136 Novel Pyrrolo [3,2-D]Pyrimidin-4-One Derivatives And Their Use In Therapy 09-11-2008
159. 20080221133 Compounds - compound according to Formula whereinR 09-11-2008
160. 20080214605 Alkyl Sulfoxide Quinolines as Nk-3 Receptor Ligands 09-04-2008
161. 20080214578 Novel 5-Substituted 7-Amino-[1,3]Thiazolo[4,5-D]Pyrimidine Derivatives 793 09-04-2008
162. 20080214577 New Compounds 320 - This invention relates to novel compounds having the structural formula I below: and to their pharmaceutically acceptable salt 09-04-2008
163. 20080214570 Therapeutic Agents - compounds of formula I and processes for preparing such compounds 09-04-2008
164. 20080214560 Use of Pyrimidine Derivatives in the Manufacture of a Medicament for Prevention and/or Treatment of Alzheimer's Disease 09-04-2008
165. 20080207612 Benzimidazole Derivatives, Compositions Containing Them, Preparation Thereof and Uses Thereof 08-28-2008
166. 20080200504 Amide Alkyl Pyridiyl Quinolines as Nk3 Receptor Modulators 08-21-2008
167. 20080200500 Quinoline Derivatives as Nk3 Antagonists 08-21-2008